相关实验视频

Updated: May 5, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

关于家族性高胆固醇血症的最新情况:来自国家脂质协会的专家临床共识

Zahid Ahmad¹, Anandita Agarwala², Marina Cuchel³

¹Division of Endocrinology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, United States (Ahmad).

Journal of clinical lipidology

|February 25, 2026

概括

家族性高胆固醇血症 (FH),是一种导致高LDL-C的遗传疾病,在全球范围内被诊断不足. 新的指导方针强调早期查和先进疗法,以减少FH患者心血管疾病的风险.

科学领域:

心血管医学心血管医学
临床脂质学临床脂质学
遗传学是一个遗传学.

背景情况:

家族性高胆固醇血症 (FH) 是一种普遍的遗传性疾病,导致终身高LDL-C和早期动脉样硬化心血管疾病 (ASCVD).
尽管其患病率高 (311人中1人),但在全球范围内,FH的诊断严重不足.
本文档更新了2011年国家脂质协会的临床指南,反映了最近的进展.

研究的目的:

为诊断和管理家族性高胆固醇血症 (FH) 提供最新的临床指导.
强调改进的检测策略,包括基因检测和级联查.
概述基于证据的管理方法,包括用于ASCVD预防的新疗法.

主要方法:

审查FH目前的诊断标准,包括基因检测.
推普遍的儿科和系统的家庭级联查.
从生活方式的改变到先进的药物治疗和非的逐步治疗策略.

主要成果:

由于FH的诊断仍然不足,因此需要改进查方案.
基因检测在FH诊断和级联查中起着至关重要的作用.
强化降低LDL-C建议用于初级和二级ASCVD预防.
新型药物如PCSK9抑制剂和bempedoic酸被纳入治疗算法.

结论:

更新的指南旨在加强FH识别和患者护理.
早期和准确的诊断,加上积极的LDL-C管理,可以降低ASCVD发病率和死亡率.
解决健康差异对于公平的FH护理至关重要.

关键词:

APOBOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB APOB 级联查是指一系列的查.埃维纳库马布 (Evinacumab) 是一个家庭性高胆固醇血症是什么?超高胆固醇血症是什么情况这就是LDL-C.这就是LDLR的LDLR.脂质蛋白非热症是指脂质蛋白的非热症.在PCSK9中类他类药物是一种药物.

更多相关视频

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

相关概念视频

Lipid-derived Compounds in the Human Body

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Lipids: Dietary Sources and Requirements

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...